Detection of methicillin-resistant coagulase-negative staphylococci by the Vitek 2 system
- PMID: 24951799
- PMCID: PMC4313137
- DOI: 10.1128/JCM.01162-14
Detection of methicillin-resistant coagulase-negative staphylococci by the Vitek 2 system
Abstract
The accurate performance of the Vitek 2 GP67 card for detecting methicillin-resistant coagulase-negative staphylococci (CoNS) is not known. We prospectively determined the ability of the Vitek 2 GP67 card to accurately detect methicillin-resistant CoNS, with mecA PCR results used as the gold standard for a 4-month period in 2012. Included in the study were 240 consecutively collected nonduplicate CoNS isolates. Cefoxitin susceptibility by disk diffusion testing was determined for all isolates. We found that the three tested systems, Vitek 2 oxacillin and cefoxitin testing and cefoxitin disk susceptibility testing, lacked specificity and, in some cases, sensitivity for detecting methicillin resistance. The Vitek 2 oxacillin and cefoxitin tests had very major error rates of 4% and 8%, respectively, and major error rates of 38% and 26%, respectively. Disk cefoxitin testing gave the best performance, with very major and major error rates of 2% and 24%, respectively. The test performances were species dependent, with the greatest errors found for Staphylococcus saprophyticus. While the 2014 CLSI guidelines recommend reporting isolates that test resistant by the oxacillin MIC or cefoxitin disk test as oxacillin resistant, following such guidelines produces erroneous results, depending on the test method and bacterial species tested. Vitek 2 cefoxitin testing is not an adequate substitute for cefoxitin disk testing. For critical-source isolates, mecA PCR, rather than Vitek 2 or cefoxitin disk testing, is required for optimal antimicrobial therapy.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.
Comment in
-
Use of alternative reference standards and exempted species to evaluate the performance of the Vitek 2 GP67 cefoxitin/oxacillin screen for coagulase-negative staphylococci.J Clin Microbiol. 2015 Jan;53(1):365. doi: 10.1128/JCM.02771-14. J Clin Microbiol. 2015. PMID: 25524765 Free PMC article. No abstract available.
-
Reply to "use of alternative reference standards and exempted species to evaluate the performance of the Vitek 2 GP67 cefoxitin/oxacillin screen for coagulase-negative staphylococci".J Clin Microbiol. 2015 Jan;53(1):366. doi: 10.1128/JCM.03023-14. J Clin Microbiol. 2015. PMID: 25524766 Free PMC article. No abstract available.
References
-
- Swenson JM, Brasso WB, Ferraro MJ, Hardy DJ, Knapp CC, Lonsway D, McAllister S, Reller LB, Sader HS, Shortridge D, Skov R, Weinstein MP, Zimmer BL, Patel JB. 2009. Correlation of cefoxitin MICs with the presence of mecA in Staphylococcus spp. J. Clin. Microbiol. 47:1902–1905. 10.1128/JCM.02304-08. - DOI - PMC - PubMed
-
- Clinical and Laboratory Standards Institute. 2014. Performance standards for antimicrobial susceptibility testing; 24th informational supplement. CLSI M100-S24 Clinical and Laboratory Standards Institute, Wayne, PA.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
